{"public_id":"co_14cbbf7ee25d53a5be4c6ee6131fc5e4","status":"active","merged_into_public_id":null,"resolved_public_id":"co_14cbbf7ee25d53a5be4c6ee6131fc5e4","name":"pharmaceutical use","description":"Application of galactomannans in drug delivery and pharmaceutical formulation.","aliases":[],"types":["application"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":97106121,"title":"Pharmaceutical use of galactomannans","citation_count":46,"url":"https://sah.borca.ai/papers/97106121"}],"claims":[{"public_id":"cl_dccdde7c138a11d6ce1b7bbc1d641b00","text":"Galactomannans have been extensively studied for pharmaceutical use over the past decade.","corpus_id":97106121,"url":"https://sah.borca.ai/claims/cl_dccdde7c138a11d6ce1b7bbc1d641b00"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_14cbbf7ee25d53a5be4c6ee6131fc5e4","url":"https://sah.borca.ai/concepts/co_14cbbf7ee25d53a5be4c6ee6131fc5e4"}